Phase I-IV Clinical Trials


  • The Clinical Research and Regulatory Services Division oversees Phase I to phase IV projects worldwide – from obtaining the experts’ opinion (e.g., Regulatory Agencies, KOLs…) on the most appropriate way to generate robust evidence on a medicine’s benefits and risks to developing the study design.

  • In addition, CEBIS is closely working with the pharmaceutical companies along the product developing journey – from conceiving the specific documentation to regulatory & ethics approval, data management, monitoring, project management, biostatistics, and until the research results publishing.

  • As a niche service provider, CEBIS conducts PK studies on new molecules, as well as repurposed or modified formulations. Ability to conduct Phase I studies on a patient population.
  • Conducting complex studies including FIH (SAD/MAD) and 505(b)2 products.

Phase I - IV

Clinical trials


  • has the expertise of performing Adaptive Designs for Clinical Trials of Drugs and Biologics

  • uses AI to perform clinical trial modeling and simulation, improving the efficiency of the drug development process

  • uses clinical trial technologies to improve milestones, to have high quality data, and to document all the activities performed

  • uses risk-based monitoring tools to increase the study performance

Follow us



7080, Southwest Fwy,
Houston, Texas – 77074